STAT Reports

Deep dives into the breakthroughs that are revolutionizing health care

STAT Reports help you make sense of the ever-changing health and life sciences industries — and stay abreast of the latest companies, disruptive technologies, and personalities shaping the space.

The STAT guide to viral vectors, the linchpin of gene therapy

Gene therapies were once dismissed as too dangerous to introduce to the treatment landscape. But today they are making a comeback with hundreds of products in the pipeline and under trial. In our latest STAT Report, we dive into the science, and business, of viral vector technologies. We spoke with executives from 18 companies to identify the pipeline of therapies that are nearing the clinic, the engineering and production challenges that may stifle progress, and how key players are looking to overcome those challenges. Learn more about this report.

The STAT insiders guide to the Democratic presidential candidates who could shake up drug pricing policy

This 100-page report profiles each of the Democratic hopefuls running for president in 2020 — including long-shot candidates who may nevertheless be seen as picks for vice president or cabinet roles — and analyzes their positions on drug pricing. This is an ideal report for pharma insiders, policymakers, and staffers alike, regardless of how closely you’ve been following the 2020 race so far. It provides a comprehensive understanding of how the election is likely to influence public policy debates around the country in the coming year, and what a change of party in the White House could mean for the industry overall. Learn more about this report.

Stay in the loop

To get alerts when new reports are released, sign up today.